



S1 E8 Special Episode: Forbion & University of Cambridge Judge Business School - "Building a Thriving Biotech Ecosystem: Insights from Founders, Investors, and Tech Transfer Offices"
In this special edition of the Biotech Pulse podcast, we feature a live panel discussion hosted in partnership with the University of Cambridge Judge Business School and Forbion. The event, titled Smart Capital, Leveraged Science: How VCs Unlock Biotech Potential, brings together prominent voices f…

Episode 7 - Trust, Translation, and Therapeutics: The Story of Complement Therapeutics
In the seventh episode of The Biotech Pulse, Forbion General Partner Dmitrij Hristodorov, PhD is joined by Daniela Couto, General Partner at BioGeneration Ventures (BGV), and Professor Dr. Simon Clark, co-founder of Complement Therapeutics. Together, they explore the dynamics of building biotech co…

Episode 6 - "Advancing Women's Health: Bridging Gaps in Innovation and Action"
Biotech Pulse Episode 6: Breaking Barriers in Women’s Health Innovation The sixth episode of Biotech Pulse features an in-depth look at the challenges and opportunities in women’s health innovation. The episode is introduced by our Senior Associate Vanessa Carle, PhD and focuses on the inaugural F…

Episode 5 - "Biotech Innovations and Sustainability"
In Episode 5 of The Biotech Pulse, Silva Dezelan, Head of Impact and ESG at Forbion, introduces a fireside chat from our 2023 AGM. The discussion, moderated by Charis Grasser, includes Forbion General Partner Alexander Hoffmann, Forbion Advisor & former CEO DSM Feike Sijbesma, and CSO Mosa Meat Mar…

The Biotech Pulse S1E4 - the role of biotech as the ‘discovery engine’ for pharma
This episode showcases the role of biotech as the ‘discovery engine’ for pharma in high-risk areas of R&D. It features General Partner Dmitrij (Dima) Hristodorov as he interviews Felix Lansing, co-founder and CTO of Seamless Therapeutics, together with Albert Seymour, CEO of Seamless Therapeutics, …

The Biotech Pulse S1E3 - Empowering Women's Health: A Conversation with Mary Kerr, CEO of NeRRe Therapeutics
Episode 3 of "The Biotech Pulse" features Geert-Jan Mulder, Managing Partner and one of the founders of Forbion, interviewing Mary Kerr, CEO of NeRRe Therapeutics. They discuss the challenges and opportunities in women's health, particularly in biotech. Mary shares insights into her career journey,…

Navigating the M&A Landscape for Biotech Success
In the second episode of "The Biotech Pulse" our General Partner, Nanna Lüneborg, PhD, MBA, engages in a discussion with François Ravenelle, PhD, the Chief Executive Officer of Inversago Pharma. The backdrop to this conversation is the noteworthy acquisition of Inversago by Novo Nordisk for over $1…

The Manufacturing of Complex Biologics
The first episode of The Biotech Pulse concentrates on the Manufacturing of Complex Bioligics. Forbion General Partner Rogier Rooswinkel speaks to Replimune CEO Philip Astley-Sparke. Philip Astley-Sparke is not only the company's Chief Executive Officer, but he is also its co-founder and has served…